STRS Ohio’s Adamas Pharmaceuticals ADMS Stock Holding History

STRS Ohio’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-38,800	Closed	-$561K	–	2042
2016 Q1	$561K	Sell	38,800 -1,000	-3%	-$16.8K	﹤0.01%	1210
2015 Q4	$1.13M	Buy	39,800 +12,700	+47%	+$214K	0.01%	757
2015 Q3	$453K	Hold	27,100	–	–	﹤0.01%	1317
2015 Q2	$710K	Sell	27,100 -8,700	-24%	-$169K	﹤0.01%	1140
2015 Q1	$626K	Hold	35,800	–	–	﹤0.01%	1118
2014 Q4	$622K	Buy	35,800 +33,204	+1,279%	+$504K	﹤0.01%	1118
2014 Q3	$48K	Buy	+2,596	New	+$44.7K	﹤0.01%	1654

Other funds holding ADMS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BWCA

Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CPH

C Partners Holding Zurich, Switzerland $317M AUM 4.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

STRS Ohio's ADMS Position: Q2 2016 in Review

STRS Ohio sold out of Adamas Pharmaceuticals (ADMS) in Q2 2016, closing a stake of 38,800 shares — an estimated $561K sold.

STRS Ohio first reported a position in ADMS in Q3 2014 and held it in 7 quarters. The position peaked at $1.13M in Q4 2015. 84 funds tracked by Wall St. Rank hold ADMS as of Q2 2016.

STRS Ohio reported no remaining Adamas Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
STRS Ohio sold 38,800 Adamas Pharmaceuticals shares in Q2 2016, an estimated $561K.
STRS Ohio first reported a position in Adamas Pharmaceuticals in Q3 2014 and held it in 7 quarters.
STRS Ohio's Adamas Pharmaceuticals position peaked at $1.13M in Q4 2015.
84 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q2 2016.

Based on STRS Ohio's 13F filing for Q2 2016, filed 26 Jul 2016.